Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study

Pol Arch Intern Med. 2021 Jan 29;131(1):103-110. doi: 10.20452/pamw.15735. Epub 2020 Dec 31.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Adult
  • Aged
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Drug Combinations
  • Female
  • Humans
  • Lopinavir / therapeutic use*
  • Male
  • Middle Aged
  • Poland
  • Risk Factors
  • Ritonavir / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Drug Combinations
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • remdesivir
  • Adenosine Monophosphate
  • Ritonavir
  • Alanine